AI cancer diagnosis study using electronic health records
Part of Cancer clinical trials.
This study uses artificial intelligence to analyze electronic health records (including medical history, lab results, and imaging data) to improve cancer diagnosis and prediction. It aims to help identify cancer earlier and more accurately, potentially leading to better treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have complete electronic health records, including medical history, lab tests, and any available imaging or genetic data.
- You must be able to understand the study and provide informed consent (or have a parent or guardian provide it for you).
- If you are a minor, your parent or guardian must agree for you to join.
- You cannot have severe memory or thinking problems that would make it hard to participate.
- You cannot have a terminal illness that would prevent meaningful participation.
- You cannot be pregnant (for safety reasons).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether artificial intelligence (AI) can help doctors spot early signs of cancer (breast, liver, kidney, or bladder) on routine CT scans that patients get for other reasons. The goal is to see if this 'opportunistic screening' catches cancers earlier when they may be easier to treat.
This study tests whether an artificial intelligence program can help diagnose diseases by analyzing your medical records and imaging scans. It aims to improve accuracy and speed in identifying health conditions.
This trial uses artificial intelligence to analyze your pathology slides, radiology images, and medical records together. It aims to see how well AI can help with diagnosis or treatment planning, and you may qualify if your medical data is available and of good quality.
This study is testing if artificial intelligence (AI) can look at microscope slides of your brain tumor tissue to guess its genetic makeup. It uses data already collected from your routine care, so there is no extra treatment or medicine involved.
This study tests an AI-powered program that helps doctors manage cancer patients who also have other health conditions. You may be able to join if you are starting or currently receiving cancer treatment and can use a smart device.
This trial uses artificial intelligence to analyze CT and MRI scans of solid tumors. The goal is to better understand how tumors respond to non-surgical treatments, which could help doctors make more personalized treatment decisions.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.